Overview

Efficacy of Simvastatin in Alcoholic Liver Fibrosis

Status:
Not yet recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy of simvastatin in reducing liver fibrosis in patients with advanced fibrosis due to alcohol
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Anna Cruceta
Treatments:
Simvastatin